Pune:
City-based Bilcare, the leader in pharma packaging, became
the first packaging vendor to win the OPPI Best Vendor
Award 2003 for the second time in the category of packaging
material suppliers for the second consecutive year. This
prestigious award is given out by OPPI (Organisation of
Pharmaceutical producers of India), and is selected by
an elite jury comprising pharma companies themselves.
The
much-coveted OPPI award was bagged by Bilcare for achieving
remarkable success in providing novel packaging alternatives
and services to the pharmaceutical sector, thereby giving
a new dimension to brand building through packaging. The
award consists of a citation and a plaque.
Says
OPPI director-general Dr Ajit Dangi: "It gives me
great pleasure to congratulate Bilcare for achieving the
unique distinction of winning this prestigious award for
the second time in succession. It is a well-deserved honour
and we hope Bilcare will continue this tradition."
Says
Bilcare managing director Mohan Bhandari: "This award
is a recognition of the Bilcare thought. The OPPI award
will boost the confidence of Team Bilcare in our quest
to becoming global leaders."
Bilcare
is a unique research-based organisation with a vision
to provide state-of-the-art and comprehensive packaging
solutions to the pharmaceutical and healthcare sector.
The main focus is scientific designing through path-breaking
methodologies and optimisation of packaging solutions.
Bilcare
has several firsts to its credit, including a drug master
file with US Food and Drugs Administration since 2000
for barrier films and a state-of-the-art manufacturing
facility conforming to cGMP norms. It is also one of the
first organisations to have received the ISO 14001 and
9002 accreditation. Bilcare has presence in over 13 countries
worldwide and has also set up a world-class research and
development centre near Pune.
Forging
ahead, Bilcare promises to continue on its mission to
provide comprehensive value addition in the area of packaging
research to the global pharmaceutical, nutraceutical and
healthcare sectors through its various research initiatives.
|